checkAd

     105  0 Kommentare Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)

    Für Sie zusammengefasst
    • Medacta's QUADRA-H hip stem achieves 13A* quality rating from ODEP.
    • QUADRA-H has excellent survivorship of 96.1% at 13 years.
    • Medacta's hip offering includes other highly rated products.

    Medacta Group SA / Key word(s): Miscellaneous
    Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)

    08.01.2024 / 19:00 CET/CEST


    MEDIA RELEASE

    Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)

    CASTEL SAN PIETRO, 8 January 2024 - Medacta Group S.A. ("Medacta," SIX: MOVE), a Swiss company featuring innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgeries, is pleased to announce that the QUADRA-H hip stem was awarded 13A* by the Orthopaedic Data Evaluation Panel (ODEP), an independent panel of experts in the United Kingdom assessing objective evidence on the performance of medical implants. This valuable result is based on data from national registries pertaining to several thousand cases, which showed an excellent cumulative survivorship of 96.1% at 13 years.[1]

    With 20 years of clinical history, QUADRA-H represents the first stem designed by Medacta. It features a triple-tapered design and is made of Titanium-Niobium alloy with an HA (hydroxyapatite) coating. This design allows for an effective rotational and axial stability, which is further enhanced by the HA coating, potentially leading to long-term fixation and to better patient outcomes.

    QUADRA-H is part of the QUADRA System, a comprehensive system of rectangular straight stems to be used in both primary and revision surgeries. Available in an extensive range of sizes for multiple stem versions, QUADRA system allows for a high personalized approach.

    “The QUADRA-H stem has been my implant of choice for over a decade. The compatibility of this stem with the AMIS approach has consistently resulted in positive patient outcomes. Its reliability and effectiveness have made it an invaluable tool in my practice,” says Dr. Jonathan Young from Lake Macquarie Private Hospital, Gateshead, Australia. 

    The AMIS (Anterior Minimally Invasive Surgery) technique is an easily reproducible technique that delivers significant benefits to patients, surgeons, and healthcare systems. The orthopaedic community has widely embraced this minimally invasive approach, which has been chosen by surgeons to be used in more than 500,000 patients worldwide.

    Seite 1 von 4



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP) Medacta Group SA / Key word(s): Miscellaneous Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP) 08.01.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta’s QUADRA-H hip stem …